Our novel class of drugs has the potential to be an essential therapy in the treatment of serious inflammatory and fibrotic diseases, including systemic sclerosis, chronic kidney disease, focal segmental glomerulosclerosis, diabetic retinopathy and other diseases.
Our mission is to advance these novel therapeutics through clinical development to provide precision medicine treatments for these conditions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.